S. C. Hughes

Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease

J. Holly, A. Gimson, R. Ross, 1995, Hepatology.

Changes in circulating insulin-like growth factor-binding protein-1 (IGFBP-1) during prolonged exercise: effect of carbohydrate feeding.

P. Jakeman, J. Holly, J. Holly, 1994, The Journal of clinical endocrinology and metabolism.

Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease.

J. Holly, R. Ross, W. Blum, 1996, Critical care medicine.

Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety.

J. Holly, A. Gimson, R. Williams, 1997, Gastroenterology.

Could abnormalities in insulin-like growth factors and their binding proteins during pregnancy result in gestational diabetes?

J. Holly, G. Heinrich, M. Johnson, 1995, The Journal of endocrinology.

The differential regulation of the circulating levels of the insulin‐like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery

W. Blum, A. Cotterill, R. Langford, 1996, Clinical endocrinology.

Growth hormone, insulinlike growth factor‐1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease

J. Holly, A. Gimson, R. Ross, 1995, Hepatology.

Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin‐like growth factors and IGF binding proteins 1 and 3: a cross‐over study

P. Lønning, J. Holly, S. Helle, 1996, Clinical endocrinology.